GlassScriptPhysician profile
David A Shneider
NPI 1255306791
$3,067.71
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,745 · 2020: $1,311 · 2021: $12.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,359.14 | 2019-2020 | |
| Smith+Nephew, INC. | $333.65 | 2019-2020 | |
| Depuy Synthes Sales INC. | $101.64 | 2019-2020 | |
| Tracpatch Health, INC | $72.93 | 2020 | |
| Avanos Medical | $33.59 | 2019 | |
| Merck Sharp & Dohme LLC | $25.26 | 2019 | |
| Mallinckrodt Enterprises LLC | $22.26 | 2019 | |
| Pacira Therapeutics, INC. | $21.86 | 2019 | |
| Fidia Pharma USA INC. | $18.65 | 2020 | |
| Endo Pharmaceuticals INC. | $14.60 | 2020 | |
| Orthofix Medical, INC. | $14.57 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.12 | 2019 | |
| Osteomed LLC | $12.25 | 2021 | |
| Bioventus LLC | $12.13 | 2020 | |
| Stryker Corporation | $11.06 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.